Frankfurt, May 6, 2026, 14:04 (CEST)
Siemens shares climbed on Wednesday, rising 3.65% to 270.00 euros by 13:55 CEST, as the German industrial group recovered from recent weak sessions and outpaced a strong DAX market. The stock remained just 2.09% below its 52-week high of 275.75 euros.
The move matters because it comes one week before Siemens reports second-quarter results, a release investors are likely to use to test whether demand in automation, electrification and industrial software is still strong enough to support the stock’s run. Siemens has said it will publish fiscal second-quarter figures on May 13.
UBS kept Siemens at “Buy,” an analyst recommendation to purchase the stock, with a 255-euro target price, finanzen.net reported, citing dpa-AFX Analyser. Analyst Andre Kukhnin pointed to positive impulses from Rockwell Automation’s results and outlook, though the UBS target stood below the Xetra price of 269.85 euros quoted at 13:36 CEST. Finanzen
The broader market also helped. Bloomberg data showed the DAX trading at 25,050.16, up 2.66%, with the German benchmark still open at the time of the quote.
Rockwell, a U.S. automation peer, reported fiscal second-quarter sales up 12% and organic sales up 9%, while lifting its 2026 sales-growth outlook. Chief Executive Blake Moret said Rockwell delivered “double-digit growth in sales and earnings exceeding our expectations,” with demand improving in warehouse automation, data centers, semiconductors and energy. Rockwell Automation
Siemens had already raised its fiscal 2026 outlook after a strong first quarter. The company reported orders of 21.4 billion euros, revenue of 19.1 billion euros and industrial profit of 2.9 billion euros; its book-to-bill ratio, which compares new orders with sales booked in the period, stood at 1.12. Chief Executive Roland Busch said “Artificial intelligence is a strong growth driver for our businesses.” Siemens Press
For the full year, Siemens expects comparable revenue growth of 6% to 8% and earnings per share before purchase-price accounting of 10.70 euros to 11.10 euros. It also flagged negative currency effects as a burden on nominal growth and profit, a reminder that not all of the operating strength will flow cleanly into reported numbers.
The portfolio story is also back in view. Siemens said in April it plans to put a direct spin-off of Siemens Healthineers shares to a shareholder vote at its annual general meeting in February 2027, with Siemens shareholders to receive Healthineers shares directly if the transaction proceeds.
A separate Aktienwelt360 column by investment analyst Caio Reimertshofer argued that Siemens still has valuation room despite trading near record levels, citing a forward price-earnings ratio around 23 and a price-to-sales ratio of 2.8. The column said Honeywell and Emerson, two U.S. industrial peers, trade at roughly four to five times sales despite similar structures.
But the setup is not one-way. UBS’ target price implies downside from Wednesday’s intraday quote, while Digital Industries remains exposed to slower factory investment and any renewed automation downturn. Siemens itself has warned of currency pressure, and its outlook excludes burdens from legal and regulatory matters.
That leaves May 13 as the next clean test. Investors will be looking less for a headline beat than for evidence that order intake, margin quality and cash conversion can hold together after a sharp share-price recovery.
